127 related articles for article (PubMed ID: 8881233)
1. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
Remsen LG; McCormick CI; Roman-Goldstein S; Nilaver G; Weissleder R; Bogdanov A; Hellström I; Kroll RA; Neuwelt EA
AJNR Am J Neuroradiol; 1996 Mar; 17(3):411-8. PubMed ID: 8881233
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
Varallyay P; Nesbit G; Muldoon LL; Nixon RR; Delashaw J; Cohen JI; Petrillo A; Rink D; Neuwelt EA
AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
[TBL] [Abstract][Full Text] [Related]
3. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery.
Muldoon LL; Pagel MA; Kroll RA; Roman-Goldstein S; Jones RS; Neuwelt EA
AJNR Am J Neuroradiol; 1999 Feb; 20(2):217-22. PubMed ID: 10094341
[TBL] [Abstract][Full Text] [Related]
4. Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide.
Small WC; Nelson RC; Bernardino ME
Magn Reson Imaging; 1993; 11(5):645-54. PubMed ID: 8345779
[TBL] [Abstract][Full Text] [Related]
5. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
6. Cerebral iron oxide distribution: in vivo mapping with MR imaging.
Zimmer C; Weissleder R; O'Connor D; LaPointe L; Brady TJ; Enochs WS
Radiology; 1995 Aug; 196(2):521-7. PubMed ID: 7617871
[TBL] [Abstract][Full Text] [Related]
7. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts.
Neuwelt EA; Barnett PA; Ramsey FL; Hellström I; Hellström KE; McCormick CI
Neurosurgery; 1993 Sep; 33(3):478-84; discussion 484. PubMed ID: 8413880
[TBL] [Abstract][Full Text] [Related]
9. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
10. Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging.
Knauth M; Egelhof T; Roth SU; Wirtz CR; Sartor K
AJNR Am J Neuroradiol; 2001 Jan; 22(1):99-102. PubMed ID: 11158894
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
[TBL] [Abstract][Full Text] [Related]
12. Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model.
Remsen LG; Trail PA; Hellström I; Hellström KE; Neuwelt EA
Neurosurgery; 2000 Mar; 46(3):704-9. PubMed ID: 10719867
[TBL] [Abstract][Full Text] [Related]
13. Passage of DMP across a disrupted BBB in the context of antibody-mediated MR imaging of brain metastases.
Bulte JW; de Jonge MW; de Leij L; The TH; Kamman RL; Blaauw B; Zuiderveen F; Go KG
Acta Neurochir Suppl (Wien); 1990; 51():43-5. PubMed ID: 1708649
[TBL] [Abstract][Full Text] [Related]
14. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
15. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
[TBL] [Abstract][Full Text] [Related]
16. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
[TBL] [Abstract][Full Text] [Related]
17. Reversibility of experimental acute renal failure in rats: assessment with USPIO-enhanced MR imaging.
Laissy JP; Idée JM; Loshkajian A; Benderbous S; Chillon S; Beaufils H; Schouman-Claeys E
J Magn Reson Imaging; 2000 Aug; 12(2):278-88. PubMed ID: 10931591
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging.
Senéterre E; Weissleder R; Jaramillo D; Reimer P; Lee AS; Brady TJ; Wittenberg J
Radiology; 1991 May; 179(2):529-33. PubMed ID: 2014305
[TBL] [Abstract][Full Text] [Related]
19. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent.
Enochs WS; Harsh G; Hochberg F; Weissleder R
J Magn Reson Imaging; 1999 Feb; 9(2):228-32. PubMed ID: 10077018
[TBL] [Abstract][Full Text] [Related]
20. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.
Wu X; Hu J; Zhou L; Mao Y; Yang B; Gao L; Xie R; Xu F; Zhang D; Liu J; Zhu J
J Neurosurg; 2008 Feb; 108(2):320-9. PubMed ID: 18240929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]